Young Researchers Share Benefits of Global Scholar-in-Training Program
Four of the 2023 GSITA recipients explain how the program has benefited their careers.
Category: Grants
Four of the 2023 GSITA recipients explain how the program has benefited their careers.
Lobular breast cancer accounts for 15% of all breast cancer cases, but it is understudied.
In 2022, AACR launched a unique initiative called AACR Maximizing Opportunity for New Advancements in Research in Cancer (MONARCA)...
For the past five years, cohorts of talented young researchers from around the world have participated in the AACR...
Neuroblastoma, a rare cancer that occurs primarily in children, is a scientific paradox, said pediatric oncologist John M. Maris,...
A long and fruitful partnership in the world of cancer research began in 2006 in Hollywood with AACR CEO...
“It is more important to know what sort of person has a disease than to know what sort of...
The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career...
The AACR is pleased to offer the Global Scholar-in-Training Awards (GSITA) to eligible early-career investigators in countries building cancer...
After a hiatus caused by the pandemic, Party with a Purpose, a cause-driven gala in Philadelphia that supports cancer...